Reports

At a Science|Business meeting in Trondheim, clinical specialists, tech  experts, patients and policymakers debated how to use health registry data to achieve better patient outcomes

France, Canada and others are pushing for some international ‘rules of the road’ for artificial intelligence. But differing cultures, industries and policies complicate efforts to develop a global approach, say international experts at a Science|Business conference

A report of the Science|Business Network’s Cloud Consultation Group

The EU is now planning its biggest-ever R&D programme. Science|Business, drawing on its independent news coverage, takes you through what it’s all about, so you can start preparing  

The EU want its new R&D programme to have high 'impact.' Science|Business proposes some ways to get there. 

The EU needs an ambitious and coherent agenda for the 2019-2024 legislative term to boost the resilience, equitability and sustainability of Europe’s healthcare systems. This report, based on a Science|Business expert roundtable, sets out recommendations for such an agenda.

Europe's creative and cultural industries are big, important and growing fast. How can EU programmes help? A Science|Business workshop, supported by the European Commission, gathered suggestions. Here are the results. 

A special report of the Science|Business Network

This report explores the case for open science, illustrated by use cases and case studies, spanning academia, start-ups and enterprises. It seeks to explain why public sector and private sector researchers should support open science by highlighting concrete examples of disciplinary breakthroughs that have been fuelled by the sharing of research data, tools and infrastructure.

A special report of the Science|Business Network

The Netherlands has embarked on a five year national plan to use health data to improve outcomes for patients and increase the cost effectiveness of its healthcare system. In this report, public health experts and patient representatives discuss progress to date

A study of breast cancer specialists across the EU. 
Supported by COCIR.